François Emery Cotté
About François Emery Cotté
François Emery Cotté is the Directeur Associé Médico-Économie and Santé Publique at Bristol-Myers Squibb, specializing in immuno-oncology and cardiology.
Current Role at Bristol-Myers Squibb
François Emery Cotté is currently serving as the Directeur Associé Médico-Économie and Santé Publique - Immuno-Oncology and Cardiology at Bristol-Myers Squibb. His role involves overseeing public health and health economics-related activities, focusing primarily on the fields of immuno-oncology and cardiology. He has been with the company since January 2014.
Past Experience at Bristol-Myers Squibb
Prior to his current role, François Emery Cotté held the position of Associate Director in Health Economics and Outcomes Research for Diabetes and Cardiology from 2011 to 2013 in New York, New York. During this time, he developed and led research initiatives aimed at improving health outcomes and economic evaluations in these therapeutic areas.
Leadership at GSK
François Emery Cotté spent six years at GlaxoSmithKline (GSK) as the Health Outcomes Project Leader for Oncology, Rheumatology, and Urology. From 2005 to 2011, he managed projects aimed at evaluating and improving health outcomes in these specialized medical fields. He also briefly worked in the Regulatory Affairs department in 2004.
Educational Background
François Emery Cotté has a diverse educational background. He spent a year at Sciences Po from 2015 to 2016. He earned his Doctor of Philosophy from Paris-Sud University (Paris XI) from 2006 to 2009. Additionally, he completed a Master of Public Health at the School of Public Health (Paris XI) from 2005 to 2006. He also attended IAE France - Écoles Universitaires de Management for a year from 2003 to 2004. His early education includes a Master of Science and Doctor of Pharmacy from the School of Pharmacy, Caen, which he completed over seven years from 1998 to 2005.